Senti Biosciences Inc. (NASDAQ: SNTI)
$0.31
-0.0092 ( -2.92% ) 690.8K
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
Market Data
Open
$0.31
Previous close
$0.31
Volume
690.8K
Market cap
$14.18M
Day range
$0.28 - $0.31
52 week range
$0.21 - $1.09
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 09, 2024 |
10-q | Quarterly Reports | 79 | May 09, 2024 |
3 | Insider transactions | 2 | May 09, 2024 |
8-k | 8K-related | 13 | May 02, 2024 |
8-k | 8K-related | 13 | Apr 26, 2024 |
10-k/a | Quarterly Reports | 16 | Apr 26, 2024 |
8-k | 8K-related | 15 | Mar 21, 2024 |
10-k | Annual reports | 126 | Mar 21, 2024 |
8-k | 8K-related | 14 | Feb 06, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |